Priority Date: 27.06.08 (EP 20080011736)

Inhibitory anti-HER3 antibody for sensitizing melanoma metastases or refactory melanoma for treatment with chemotherapeeutic agents or radiation therapy

  • Application ID: EP09769028
  • Status: The application is deemed to be withdrawn

Attorneys

no operation time available
Headquarter in Berlin and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing
operating since 1882
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). ABK Patent, Trademark and Design Attorneys is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 27.06.2008 - Priority Date (EP 20080011736)
  • 30.12.2009 - Publication A1 (WO2009156179)
  • 09.03.2011 - Publication A1 (EP2291398)